BSE filing, NSE: LOTUSEYE. Summary written from the filing by ALFA Finder's alert engine.
Lotus Eye Hospital and Institute Ltd: key numbers
- Share price
- ₹109.12
- Market cap
- ₹226.9 Cr
- Revenue (annual)
- ₹53.71 Cr
- Net profit (annual)
- ₹0.08 Cr
- P/E (TTM)
- 1520.0×Sector 51.1×
- Promoter holding
- 40.14%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lotus Eye Hospital and Institute Ltd
All →Lotus Eye Hospital and Institute Annual General Meeting
Lotus Eye Hospital And Institute Limited held its 29th Annual General Meeting on September 23, 2026, via video conferencing to discuss company operations and financial highlights.
Lotus Eye Hospital and Institute Annual General Meeting
Lotus Eye Hospital and Institute Limited will hold its 29th Annual General Meeting on September 23, 2026. The company has dispatched the Notice and Annual Report for FY 2025-26.
Lotus Eye Hospital and Institute Capacity Expansion
Lotus Eye Hospital and Institute Limited launched 'Lotus Optique', a new optical retail store in Coimbatore. The facility integrates professional eye care with quality eyewear products.
Lotus Eye Hospital and Institute Q1 FY27 Results: Net Profit ₹0.6 Cr, Up 20.0% YoY
Lotus Eye Hospital and Institute Ltd reported revenue from operations of ₹17.1 Cr (+26.7% YoY) and net profit of ₹0.6 Cr (+20.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.6 Cr · +20.0% YoY
Lotus Eye Hospital and Institute Board Meeting Date
Lotus Eye Hospital and Institute will hold a board meeting on August 10, 2026, to approve the company's standalone unaudited financial results for the June quarter.
Lotus Eye Hospital and Institute Other Announcement
Lotus Eye Hospital submitted its Annual Secretarial Compliance Report for FY2026. A ₹1.02 Crore fine was paid for delayed shareholder approval regarding a director's appointment.
- Value
- ₹1.02 Cr
- Execution
- Financial Year ended March 31, 2026
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.